Loading...

Gilead Sciences, Inc.

GILD.SWSIX
Healthcare
Biotechnology
CHF66.00
CHF0.00(0.00%)

Gilead Sciences, Inc. (GILD.SW) Stock Overview

Explore Gilead Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 68.1/100

Key Financials

Market Cap0
P/E Ratio13.87
EPS (TTM)N/A
ROE0.32%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

GILD.SW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Gilead Sciences, Inc. (GILD.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.87 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;